FinEdge Labs
T

TMO

TMOVerified
4 segments tracked|7 years of data|Annual (10-K)
Total Revenue
$44.6B3.9%
FY2025
Operating Segments
4
Active segments
Blended Margin
22.7%
Operating margin
Highest Margin
42.9%
Life Sciences Solutions
Segment Shift

Life Sciences Solutions has grown from 40.5% to 19.7% of total revenue since FY2018, with 42.9% operating margins.

Segment Revenue Over Time

Revenue Mix

Segment Breakdown — FY2025

SegmentRevenueOp. IncomeMargin% of TotalYoY
Laboratory Products And Biopharma Services$23.8B$3.4B14.1%53.5%+3.5%
Life Sciences Solutions$8.8B$3.8B42.9%19.7%+7.6%
Analytical Instruments$7.4B$1.7B23.6%16.5%+1.2%
Specialty Diagnostics$4.6B$1.3B27.3%10.3%+3.5%

Want more? Unlock the full analysis.

Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.

Get Started Free